Pathologists

US LABS utilizes state-of-the-art methods and technologies to analyze specimens for cancer.

Cell Staining with Dyes. We screen specimens with nuclear and cytoplasmic dyes, such as Hematoxylin and Eosin ("H&E"). These tests enhance visibility of cell morphology at a low cost and enable efficient screening and initial diagnosis.

Immunohistochemical (IHC) Analysis using Polyclonal and Monoclonal antibodies. Cancer is a disease and therefore has a characteristic antigenicity; each disease has its own specific antigen characteristic. By matching the monoclonal and polyclonal antibodies from known cancer types to a tumor biopsy, a pathologist can determine exact origin and nature of a cancer. This technology is difficult to perform, but is well established and is a standard of care.

Tumor Markers. One of the most promising growth areas within the diagnostic market is the use of new classes of tumor markers to more accurately identify and manage cancer patients. Tumor markers are usually proteins that provide information about a malignancy. This information can be useful in detecting and staging cancer, determining the origin of metastatic cancer, predicting how a tumor will respond to treatment, and identifying disease recurrence.